← Return to Vaccine against MAC?

Discussion

Vaccine against MAC?

MAC & Bronchiectasis | Last Active: Dec 20, 2020 | Replies (50)

Comment receiving replies
@rits

This is a very interesting discussion. Thank you to those who participated. I agree with Sue that there just isn't enough monry available for the research needed to develop a vaccine (assuming one is possible) for our comparatively small number of patients

It is important to remember that the bacteria is around everyone, but the vast majority of people do not become infected. One must have a problem with the lungs making them unable to clear any inhaled bacteria. For most of us, the problem is bronchiectasis. If we had a cure for that, we would be like the rest of the world and be able to inhale and exhale MAC or any other mycobacteria or bacteria and be just fine. We could even sit in a hot tub.

Jump to this post


Replies to "This is a very interesting discussion. Thank you to those who participated. I agree with Sue..."

A promising event recently occurred that some day may bring help to us. On November 13, Insmed, the pharmaceutical company behind Arikayce, received a PRIME designation from the European Medicine Agency for their drug BRENSOCATIB. This drug is an oral med that stops the release of a protein that actuates neutrophils which release an enzyme that damages the lungs of people with bronchiectasis.

A PRIME designation supports continuing research to bring promising treatment to patients.